

Cryptococcus is a fungal pathogen that primarily affects the lungs and can spread to other organs, including the brain, leading to severe conditions such as cryptococcal meningitis. While healthy individuals often clear the infection without major symptoms, immunocompromised people are at a higher risk of developing serious and potentially life-threatening illnesses.
The Cryptococcus Antigen Detection, Serum test helps in the early and reliable detection of infection by identifying specific antigens shed by the fungus, particularly Cryptococcus neoformans or Cryptococcus gattii. Detecting these antigens early is crucial, as cryptococcal infection can spread quickly in the body if not treated.
Your doctor may recommend this test if you have symptoms such as persistent headache, fever, cough, chest pain, confusion, or vision problems, particularly if you are immunocompromised. The test is especially advised for individuals with HIV/AIDS, those undergoing chemotherapy or long-term immunosuppressive therapy, and transplant recipients. It may also be recommended for people previously exposed to Cryptococcus or at risk of relapse. Additionally, this test helps doctors check how well the treatment is working.
Usually, no special preparation is required for this test. You may eat and drink as per your daily routine. However, it is preferred that you share your clinical history, current medications, and supplement use with your doctor before giving the sample, as these may influence the results.
Test result ranges are approximate and may differ slightly between labs depending on the methodology and laboratory guidelines. Do not self-medicate, and always consult a doctor to understand the test results correctly.
Please note: This is an outsourced test. The sample is collected by TATA 1MG and processed at a NABL accredited partnered lab.
The Cryptococcus Antigen Detection, Serum test detects the presence of antigens from the capsule of Cryptococcus neoformans or Cryptococcus gattii in blood. These antigens are released during fungal infection and circulate in the body, making them detectable even when fungal cultures may take longer to grow. A positive result usually indicates an active cryptococcal infection and warrants prompt antifungal treatment. A negative result suggests that infection is unlikely, though additional testing may be required if symptoms strongly suggest cryptococcosis. This test is more sensitive than microscopy or culture, especially in detecting early or disseminated infection. Accurate and timely diagnosis can significantly improve treatment outcomes and reduce the risk of life-threatening complications such as cryptococcal meningitis.
The Cryptococcus Antigen Detection, Serum test is done:
- To diagnose cryptococcal infection caused by Cryptococcus neoformans or Cryptococcus gattii
- To monitor the effectiveness of antifungal treatment
- To assess the risk of relapse or progression in high-risk patients
- To prevent complications in immunocompromised individuals
- For individuals at risk of exposure to these fungi or those with a history of previous infection
- Clinical history is preferred.






















